AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The medical device sector is considered as one of the sunrise sectors in the country
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
PEEK brings a new quality to dental care for patients
Subscribe To Our Newsletter & Stay Updated
